Switzerland - Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases
Since 2014, Switzerland Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases jumped by 3.3% year on year. With 20 Cases in 2019, the country was ranked number 224 comparing other countries in Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases. India ranked the highest with 66,255 Cases in 2019, that is an increase of 13.6% compared to 2018. India, Russia and Russia respectively ranked number 2, 3 and 4 in this ranking. Republic of the Congo witnessed the best average annual growth at +171.1% per year, while Croatia witnessed the worst performance at -100% per year.
Loading...
Date | Units (Cases) |
---|---|
2019 | 20.00 |
2018 | 19.00 |
2017 | 19.00 |
2016 | 18.00 |
2015 | 16.00 |
Download all data from 2005 to 2019
How does Switzerland rank in Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases?
# | 359 Countries | Units (Cases) | Last | YoY | 5‑years CAGR | ||
---|---|---|---|---|---|---|---|
1 |
#1
India
|
66,255 | 2019 | +13.6 % | +20.8 % | View data | |
3 |
#3
Russia
|
29,181 | 2019 | +5.0 % | +13.4 % | View data | |
223 |
#223
El Salvador
|
21 | 2019 | +250.0 % | +7.0 % | View data | |
224 |
#224
Switzerland
|
20 | 2019 | +5.3 % | +3.3 % | View data | |
226 |
#226
Tunisia
|
19 | 2019 | +0.0 % | +6.3 % | View data |